Literature DB >> 25196842

Clinical and biochemical consequences of an intragenic growth hormone receptor (GHR) deletion in a large Chinese pedigree.

Jürgen Klammt1, Shuixian Shen, Wieland Kiess, Jürgen Kratzsch, Heike Stobbe, Mandy Vogel, Feihong Luo, Roland Pfäffle.   

Abstract

OBJECTIVE: Growth hormone insensitivity (GHI) may be caused by failure of GH receptor function. Some patients bearing specific GHR mutations differ from classical GHI individuals by extremely elevated GH-binding protein (GHBP) serum concentrations. We investigated clinical, genetic and biochemical characteristics of a severely growth-retarded Chinese boy with classical Laron syndrome manifestations. PATIENTS AND MEASUREMENTS: DNA and mRNA from blood cells of the patient and 11 family members were investigated for GHR mutations. Basal GH, GHBP, IGF-1 and IGFBP-3 concentrations were determined in serum samples. The impact of the aberrant mRNA on GHR protein expression and secretion was analysed in vitro by transfection studies in HEK293 cells.
RESULTS: The proband and seven relatives had excessively elevated GHBP serum concentration. Basal GH in these individuals was significantly greater compared with family members with normal GHBP. The GHBP increase originated from a novel GHR intragenic deletion comprising parts of exon and intron 8 that caused exon 8 skipping from the GHR mRNA transcript. Transfection studies revealed that the predicted loss of plasma membrane anchorage results in direct secretion of the mutant GHR.
CONCLUSIONS: The partial GHR deletion causes excessively elevated GHBP serum concentrations regardless of the state of zygosity of the mutation. The increase in GHBP is associated with significantly elevated basal GH levels. Clinically, only homozygous carriers exhibit classical GHI manifestations. The truncated GHR protein resulting from exon 8 skipping is directly secreted out of the cell.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25196842     DOI: 10.1111/cen.12606

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Identification and In Vitro Functional Verification of Two Novel Mutations of GHR Gene in the Chinese Children with Laron Syndrome.

Authors:  Ran Li; Fengying Gong; Hui Pan; Hanting Liang; Hui Miao; Yuxing Zhao; Lian Duan; Hongbo Yang; Linjie Wang; Shi Chen; Huijuan Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

2.  Severe growth failure associated with a novel heterozygous nonsense mutation in the GHR transmembrane domain leading to elevated growth hormone binding protein.

Authors:  Ankur Rughani; Dongsheng Zhang; Kanimozhi Vairamani; Andrew Dauber; Vivian Hwa; Sowmya Krishnan
Journal:  Clin Endocrinol (Oxf)       Date:  2020-01-22       Impact factor: 3.478

Review 3.  Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report.

Authors:  Stefania Moia; Daniele Tessaris; Silvia Einaudi; Luisa de Sanctis; Gianni Bona; Simonetta Bellone; Flavia Prodam
Journal:  Ital J Pediatr       Date:  2017-10-12       Impact factor: 2.638

Review 4.  Growth Hormone Receptor Mutations Related to Individual Dwarfism.

Authors:  Shudai Lin; Congjun Li; Charles Li; Xiquan Zhang
Journal:  Int J Mol Sci       Date:  2018-05-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.